MAPK1 and melanoma: Some studies mentioned that NRAS mutation seemed to be a poor prognosis in leptomeningeal melanosis and melanomas because of the activation of both ERK and the phosphatidylinositol 3-kinase (PI3K)/AKT pathway, in contrast to ERK signaling alone in BRAF mutation cases [67,68].